Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.29% |
| 2 | Consumer Discretionary | 17.84% |
| 3 | Financials | 13.34% |
| 4 | Healthcare | 12.27% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nike
NKE
$58.7B
| $1.17B | 1.15% |
14,740,623
+3,087,189
| +26% | +$217M |
|
|
RHT
27
DELISTED
Red Hat Inc
RHT
| $1.1B | 1.07% |
8,189,596
-543,061
| -6% | -$87.6M |
|
28
BioMarin Pharmaceuticals
BMRN
$12.5B
| $1.09B | 1.06% |
11,588,631
-174,192
| -1% | -$15.3M |
|
|
ATVI
29
DELISTED
Activision Blizzard
ATVI
| $1.07B | 1.04% |
14,028,413
-1,036,182
| -7% | -$73.3M |
|
30
McDonald's
MCD
$188B
| $1.04B | 1.01% |
6,623,167
-117,029
| -2% | -$19M |
|
31
Corpay
CPAY
$26.8B
| $969M | 0.94% |
4,598,370
+577,206
| +14% | +$118M |
|
|
32
Bristol-Myers Squibb
BMY
$136B
| $965M | 0.94% |
17,446,314
-8,827,109
| -34% | -$477M |
|
33
Goldman Sachs
GS
$301B
| $938M | 0.91% |
4,253,241
-1,487,487
| -26% | -$355M |
|
34
Workday
WDAY
$49.3B
| $902M | 0.88% |
7,448,551
-82,779
| -1% | -$10.6M |
|
35
PNC Financial Services
PNC
$96.6B
| $881M | 0.86% |
6,520,884
+353,976
| +6% | +$51.6M |
|
36
Caterpillar
CAT
$368B
| $874M | 0.85% |
6,442,611
+327,470
| +5% | +$48.9M |
|
37
Vertex Pharmaceuticals
VRTX
$137B
| $861M | 0.84% |
5,063,007
-1,712,321
| -25% | -$265M |
|
38
Texas Instruments
TXN
$236B
| $759M | 0.74% |
6,882,492
-1,408,751
| -17% | -$152M |
|
39
Parker-Hannifin
PH
$125B
| $757M | 0.74% |
4,857,675
-440,509
| -8% | -$75.1M |
|
|
CXO
40
DELISTED
CONCHO RESOURCES INC.
CXO
| $752M | 0.73% |
5,438,002
-270,771
| -5% | -$38.7M |
|
|
ALXN
41
DELISTED
Alexion Pharmaceuticals
ALXN
| $748M | 0.73% |
6,028,122
-1,459,471
| -19% | -$171M |
|
|
SPLK
42
DELISTED
Splunk Inc
SPLK
| $702M | 0.68% |
7,082,607
-957,102
| -12% | -$104M |
|
43
Albemarle
ALB
$16.2B
| $692M | 0.67% |
7,330,974
+1,290,510
| +21% | +$124M |
|
|
44
AstraZeneca
AZN
$252B
| $677M | 0.66% |
+9,637,084
| New | +$693M |
|
|
45
FedEx
FDX
$78.3B
| $642M | 0.63% |
2,828,926
-1,840,786
| -39% | -$456M |
|
46
Monster Beverage
MNST
$91.8B
| $605M | 0.59% |
42,200,276
-6,731,200
| -14% | -$90.9M |
|
|
47
Constellation Brands
STZ
$22.3B
| $460M | 0.45% |
2,101,846
+1,629,361
| +345% | +$368M |
|
|
CELG
48
DELISTED
Celgene Corp
CELG
| $435M | 0.42% |
5,479,822
-3,287,290
| -37% | -$273M |
|
|
XYZ
49
Block Inc
XYZ
$50.2B
| $426M | 0.42% |
6,918,122
-2,235,053
| -24% | -$123M |
|
50
Exelon
EXC
$45.3B
| $307M | 0.3% |
10,105,772
+73,210
| +0.7% | +$2.1M |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.91B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.